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Background
Colistin is an important antimicrobial treatment option
against multidrug-resistant Gram-negative bacteria. How-
ever, colistin is a large and chemically complex molecule
and information on its ability to penetrate into tissues
remains sparse. Thus, the present work investigated the
ability of microdialysis (µD) to assess pharmacokinetics
(PK) of colistin in the interstitium of soft tissues, i.e. at a
potential site of infection.
Methods
In vitro: Colistin recovery for linear CMA 66 µD probes
with a molecular weight cut-off of 100 kDa was assessed
through forward and reverse µD for different colistin con-
centrations. In vivo: Three male healthy volunteers
received a single intravenous dose of 2.5 million interna-
tional units of the inactive prodrug colistin methanesulfo-
nate. Colistin concentrations in plasma and in µD samples
obtained from two probes inserted into subcutaneous adi-
pose tissue of the thigh were determined. Retrodialysis
was used for probe calibration. In both settings, µD was
performed with and without addition of albumin to perfu-
sion solutions and colistin was quantified by liquid chro-
matography/tandem mass spectrometry (LC-MS/MS).
Results
In vitro, colistin recovery was constant over time and
showed mean recovery values of 52 ± 3 and 71 ± 8% for
forward and reverse µD, respectively. In vivo, recovery of
colistin was 43 ± 15%. In both settings, colistin recovery
was not improved by addition of albumin to µD perfusion
solutions. Due to small volumes, reliable quantification of
colistin was not possible in some µD samples, yet maxi-
mum concentrations in adipose tissue were relatively high
(0.76 ± 0.21 µg/mL) compared with those in plasma (1.2 ±
0.43 µg/mL) attesting for extra-vascular distribution.
Conclusions
The present data demonstrate the feasibility of µD for
evaluation of colistin tissue pharmacokinetics and show
opportunities for optimization of experimental setting.
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